GlassScriptPhysician profile
Alison Vurnakes
NPI 1427493071
$381.74
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.79 · 2022: $38.50 · 2023: $83.88 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $81.87 | 2019-2024 | |
| Pfizer INC. | $73.30 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $48.98 | 2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Bioventus LLC | $30.11 | 2023 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $29.88 | 2024 | |
| Rhythm Pharmaceuticals, INC. | $25.97 | 2024 | Imcivree |
| Daiichi Sankyo INC. | $24.63 | 2022 | |
| Cranial Technologies, INC | $16.49 | 2024 | Doc Band |
| Smith+Nephew, INC. | $13.87 | 2022 | |
| Neos Therapeutics, LP | $13.69 | 2019 | |
| Kaleo, INC. | $12.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Vurnakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.